VHT holdings (2026)
All 401 positions in Vanguard Health Care ETF, ranked by portfolio weight — led by LLY at 13.8%. Weights come from the fund's own SEC N-PORT filing and update daily with prices; positions in stocks ChartRow doesn't track still appear, ranked by weight, without returns. Not investment advice.
Weights are the May 31, 2026 SEC filing rolled forward on each holding's price move (as of market close, Aug 13, 2026) — an estimate of today, not the filed figure. Switch the table below to see them exactly as filed.
Top 10 holdings#
Sector weights#
Estimated portfolio characteristics#
Estimated by our own bottom-up analysis of the fund's SEC-filed holdings, covering 93% of portfolio weight (92% carries a valid trailing P/E). Funds publish similar figures on their own sites; ours are recomputed daily from public data.
VHT holdings by weight#
301–400 of 401| # | Company | Weight | Price | 1D | YTD | 1Y | Mkt cap |
|---|---|---|---|---|---|---|---|
| 301 | CytomX Therapeutics Inc | 0.01% | — | — | — | — | — |
| 302 | Altimmune Inc | 0.01% | — | — | — | — | — |
| 303 | Sana Biotechnology Inc | 0.01% | — | — | — | — | — |
| 304 | Janux Therapeutics Inc | 0.01% | — | — | — | — | — |
| 305 | Mesa Laboratories Inc | 0.01% | — | — | — | — | — |
| 306 | Tactile Systems Technology Inc | 0.01% | — | — | — | — | — |
| 307 | Allogene Therapeutics Inc | 0.01% | — | — | — | — | — |
| 308 | Ironwood Pharmaceuticals Inc | 0.01% | — | — | — | — | — |
| 309 | Maravai LifeSciences Holdings Inc | 0.01% | — | — | — | — | — |
| 310 | Pulse Biosciences Inc | 0.01% | — | — | — | — | — |
| 311 | Olema Pharmaceuticals Inc | 0.01% | — | — | — | — | — |
| 312 | ARS Pharmaceuticals Inc | 0.01% | — | — | — | — | — |
| 313 | Arvinas Inc | 0.01% | — | — | — | — | — |
| 314 | Cullinan Therapeutics Inc | 0.01% | — | — | — | — | — |
| 315 | Emergent BioSolutions Inc | 0.01% | — | — | — | — | — |
| 316 | AngioDynamics Inc | 0.01% | — | — | — | — | — |
| 317 | MeiraGTx Holdings plc | 0.01% | — | — | — | — | — |
| 318 | Prothena Corp PLC | 0.01% | — | — | — | — | — |
| 319 | Cytek Biosciences Inc | 0.01% | — | — | — | — | — |
| 320 | Phathom Pharmaceuticals Inc | 0.01% | — | — | — | — | — |
| 321 | Tyra Biosciences Inc | 0.01% | — | — | — | — | — |
| 322 | Kestra Medical Technologies In | 0.01% | — | — | — | — | — |
| 323 | MiMedx Group Inc | 0.01% | — | — | — | — | — |
| 324 | Varex Imaging Corp | 0.01% | — | — | — | — | — |
| 325 | Ocugen Inc | 0.01% | — | — | — | — | — |
| 326 | 4D Molecular Therapeutics Inc | 0.01% | — | — | — | — | — |
| 327 | XOMA Royalty Corp | 0.01% | — | — | — | — | — |
| 328 | Replimune Group Inc | 0.01% | — | — | — | — | — |
| 329 | Lexicon Pharmaceuticals Inc | 0.01% | — | — | — | — | — |
| 330 | Cross Country Healthcare Inc | 0.01% | — | — | — | — | — |
| 331 | Pacific Biosciences of California Inc | 0.01% | — | — | — | — | — |
| 332 | Perspective Therapeutics Inc | 0.01% | — | — | — | — | — |
| 333 | Evolent Health Inc | 0.01% | — | — | — | — | — |
| 334 | Aveanna Healthcare Holdings Inc | 0.01% | — | — | — | — | — |
| 335 | Myriad Genetics Inc | 0.01% | — | — | — | — | — |
| 336 | ORIC Pharmaceuticals Inc | 0.01% | — | — | — | — | — |
| 337 | Vanda Pharmaceuticals Inc | 0.01% | — | — | — | — | — |
| 338 | Fulgent Genetics Inc | 0.01% | — | — | — | — | — |
| 339 | Savara Inc | 0.01% | — | — | — | — | — |
| 340 | Community Health Systems Inc | 0.00% | — | — | — | — | — |
| 341 | Bioventus Inc | 0.00% | — | — | — | — | — |
| 342 | Editas Medicine Inc | 0.00% | — | — | — | — | — |
| 343 | Ceribell Inc | 0.00% | — | — | — | — | — |
| 344 | Septerna Inc | 0.00% | — | — | — | — | — |
| 345 | Ginkgo Bioworks Holdings Inc | 0.00% | — | — | — | — | — |
| 346 | Prime Medicine Inc | 0.00% | — | — | — | — | — |
| 347 | Evolus Inc | 0.00% | — | — | — | — | — |
| 348 | REGENXBIO Inc | 0.00% | — | — | — | — | — |
| 349 | OrthoPediatrics Corp | 0.00% | — | — | — | — | — |
| 350 | Simulations Plus Inc | 0.00% | — | — | — | — | — |
| 351 | Zenas Biopharma Inc | 0.00% | — | — | — | — | — |
| 352 | Orthofix Medical Inc | 0.00% | — | — | — | — | — |
| 353 | Standard BioTools Inc | 0.00% | — | — | — | — | — |
| 354 | OraSure Technologies Inc | 0.00% | — | — | — | — | — |
| 355 | Fate Therapeutics Inc | 0.00% | — | — | — | — | — |
| 356 | Anavex Life Sciences Corp | 0.00% | — | — | — | — | — |
| 357 | Ardent Health Partners Inc | 0.00% | — | — | — | — | — |
| 358 | Fulcrum Therapeutics Inc | 0.00% | — | — | — | — | — |
| 359 | Akebia Therapeutics Inc | 0.00% | — | — | — | — | — |
| 360 | Rocket Pharmaceuticals Inc | 0.00% | — | — | — | — | — |
| 361 | GoodRx Holdings Inc | 0.00% | — | — | — | — | — |
| 362 | Atea Pharmaceuticals Inc | 0.00% | — | — | — | — | — |
| 363 | Rezolute Inc | 0.00% | — | — | — | — | — |
| 364 | OmniAb Inc | 0.00% | — | — | — | — | — |
| 365 | First Tracks Biotherapeutics Inc | 0.00% | — | — | — | — | — |
| 366 | Quantum-Si Inc | 0.00% | — | — | — | — | — |
| 367 | Arcturus Therapeutics Holdings Inc | 0.00% | — | — | — | — | — |
| 368 | Humacyte Inc | 0.00% | — | — | — | — | — |
| 369 | MacroGenics Inc | 0.00% | — | — | — | — | — |
| 370 | Upstream Bio Inc | 0.00% | — | — | — | — | — |
| 371 | SIGA Technologies Inc | 0.00% | — | — | — | — | — |
| 372 | Zentalis Pharmaceuticals Inc | 0.00% | — | — | — | — | — |
| 373 | Embecta Corp | 0.00% | — | — | — | — | — |
| 374 | Verastem Inc | 0.00% | — | — | — | — | — |
| 375 | RxSight Inc | 0.00% | — | — | — | — | — |
| 376 | Keros Therapeutics Inc | 0.00% | — | — | — | — | — |
| 377 | Accendra Health Inc | 0.00% | — | — | — | — | — |
| 378 | Treace Medical Concepts Inc | 0.00% | — | — | — | — | — |
| 379 | Alector Inc | 0.00% | — | — | — | — | — |
| 380 | Organogenesis Holdings Inc | 0.00% | — | — | — | — | — |
| 381 | Multiplan Corp | 0.00% | — | — | — | — | — |
| 382 | Entrada Therapeutics Inc | 0.00% | — | — | — | — | — |
| 383 | Lyell Immunopharma Inc | 0.00% | — | — | — | — | — |
| 384 | Quanterix Corp | 0.00% | — | — | — | — | — |
| 385 | MaxCyte Inc | 0.00% | — | — | — | — | — |
| 386 | Heron Therapeutics Inc | 0.00% | — | — | — | — | — |
| 387 | Neumora Therapeutics Inc | 0.00% | — | — | — | — | — |
| 388 | Korro Bio Inc | 0.00% | — | — | — | — | — |
| 389 | LENZ Therapeutics Inc | 0.00% | — | — | — | — | — |
| 390 | Aldeyra Therapeutics Inc | 0.00% | — | — | — | — | — |
| 391 | Health Catalyst Inc | 0.00% | — | — | — | — | — |
| 392 | Filana Therapeutics Inc | 0.00% | — | — | — | — | — |
| 393 | Pliant Therapeutics Inc | 0.00% | — | — | — | — | — |
| 394 | ALX Oncology Holdings Inc | 0.00% | — | — | — | — | — |
| 395 | DocGo Inc | 0.00% | — | — | — | — | — |
| 396 | Gossamer Bio Inc | 0.00% | — | — | — | — | — |
| 397 | Definitive Healthcare Corp | 0.00% | — | — | — | — | — |
| 398 | Hologic Inc | 0.00% | — | — | — | — | — |
| 399 | Roche Holding AG | 0.00% | — | — | — | — | — |
| 400 | Prevail Therapeutics Inc | 0.00% | — | — | — | — | — |
Methodology#
Holdings and weights are sourced from the fund's portfolio as disclosed to the SEC on Form N-PORT — a public filing. Portfolio filings are quarterly (public ~60 days after quarter end), so we anchor on the latest one and roll each weight forward daily by that holding's price move, keeping the numbers current between filings; positions in stocks ChartRow doesn't track carry their filed weight unchanged and show "—" where we have no data. Returns are total returns (dividends reinvested). One row per company, not per ticker: when a fund holds more than one share class of the same company (Alphabet's GOOGL and GOOG, for example), we combine them into a single row whose weight is the sum of its classes. Past performance does not predict future returns; not investment advice.
FAQ#
- What are the top 10 holdings of VHT?
- VHT's top 10 holdings are Eli Lilly and Company (LLY), 13.8%; Johnson & Johnson (JNJ), 8.8%; AbbVie Inc. (ABBV), 6.3%; UnitedHealth Group Incorporated Common Stock (DE) (UNH), 5.1%; Merck & Co. Inc. (MRK), 4.8%; Amgen Inc. (AMGN), 3.2%; Thermo Fisher Scientific Inc. (TMO), 3.2%; Abbott Laboratories (ABT), 2.7%; Gilead Sciences Inc. (GILD), 2.4%; Pfizer Inc. (PFE), 2.2% — together about 52% of the fund, per its May 31, 2026 SEC filing with weights rolled forward to today.
- How many holdings does VHT have?
- Vanguard Health Care ETF (VHT) held 401 positions as of its latest SEC N-PORT filing (May 31, 2026).
- How current are VHT's holdings?
- Funds disclose their full portfolio to the SEC on Form N-PORT; the quarter-end report becomes public about 60 days later. ChartRow anchors on the latest public filing (May 31, 2026) and rolls each weight forward daily by that holding's price move, so the weights shown estimate today rather than the filing date.
- Is ChartRow affiliated with VHT or Vanguard?
- No. ChartRow is independent and is not affiliated with, sponsored by, or endorsed by Vanguard or Vanguard Health Care ETF. Everything on this page is derived independently from the fund's public SEC filings; fund names and trademarks belong to their owners. For information only — not investment advice.